Obesity and diabetes: An update
Tóm tắt
Từ khóa
Tài liệu tham khảo
International Diabetes Federation, 2015
Solange S. Pereira, Jacqueline I. Alvarez-Leite, Low-Grade Inflammation, Obesity, and Diabetes. Metabolism (R Pasquali, Section Editor) Current Obesity Reports (2014); 3(4): 422–431.
Hossain, 2007, Obesity and diabetes in the developing world—a growing challenge, N Engl J Med, 356, 213, 10.1056/NEJMp068177
Ng, 2014, Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 5, 766, 10.1016/S0140-6736(14)60460-8
Felber, 2002, Pathways from obesity to diabetes, Int J Obes Relat Metab Disord, 26, 39, 10.1038/sj.ijo.0802126
Chen, 1987, Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus, J Clin Endocrinol Metab, 64, 17, 10.1210/jcem-64-1-17
Baldeweg, 2000, on behalf of the European Group for the Study of Insulin Resistance (EGIR) Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans, Eur J Clin Invest, 30, 45, 10.1046/j.1365-2362.2000.00597.x
Lönnqvist, 1995, A pathogenic role of visceral β3 adrenoceptors in obesity, J Clin Invest, 95, 1109, 10.1172/JCI117758
Ferrannini, 1983, Effect of fatty acids on glucose production and utilization in man, J Clin Invest, 72, 1737, 10.1172/JCI111133
Shulman, 1989, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13 C nuclear magnetic resonance spectroscopy, New Engl J Med, 322, 223, 10.1056/NEJM199001253220403
Golay, 1984, Study on lipid metabolism in obesity diabetes, Metabolism, 33, 111, 10.1016/0026-0495(84)90121-5
Felber, 1987, Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II Diabetes, Diabetes, 36, 1341, 10.2337/diab.36.11.1341
Ravussin, 2002, Increased fat intake impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus, Ann NY Acad Sci, 967, 363, 10.1111/j.1749-6632.2002.tb04292.x
Lewis, 2002, Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes, Endocr Rev, 23, 201, 10.1210/edrv.23.2.0461
Ouchi, 2011, Adipokines in inflammation and metabolic disease, Nat Rev Immunol, 11, 85, 10.1038/nri2921
Hotamisligil, 2008, Inflammation and endoplasmic reticulum stress in obesity and diabetes, Int J Obes (Lond), 32, 52, 10.1038/ijo.2008.238
Matia-García, 2014, Macrophage migration inhibitory factor and its relationship with obesity and diabetes, Invest Clin, 55, 266
Vincent, 2004, Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo, Diabetes, 53, 1418, 10.2337/diabetes.53.6.1418
Levy, 2008, Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus, Circulation, 118, 968, 10.1161/CIRCULATIONAHA.107.763730
Savoia, 2007, Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions, Clin Sci, 112, 375, 10.1042/CS20060247
Scalia, 2007, Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: the role of mu-calpain, Diabetes, 56, 1842, 10.2337/db06-1198
Akasaka, 1997, Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus, J Am Coll Cardiol, 30, 935, 10.1016/S0735-1097(97)00242-8
Yokoyama, 1997, Reduced myocardial blood flow reserve in non-insulin dependent diabetes mellitus, J Am Coll Cardiol, 30, 1472, 10.1016/S0735-1097(97)00327-6
Prior, 2005, Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus, Circulation, 111, 2291, 10.1161/01.CIR.0000164232.62768.51
Kawata, 2006, Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist, Am Heart J, 151, e9
Sundell, 2004, Association between insulin resistance and reduced coronary vasoreactivity in healthy subjects, Can J Cardiol, 20, 691
Khan, 2003, Impaired microvascular function in normal children: effects of adiposity and poor glucose handling, J Physiol, 551, 705, 10.1113/jphysiol.2003.045351
Frisbee, 2005, Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome, Am J Physiol Regul Integr Comp Physiol, 289, 307, 10.1152/ajpregu.00114.2005
Ijzerman, 2006, TNF-alpha levels are associated with skin capillary recruitment in humans: a potential explanation for the relationship between TNF-alpha and insulin resistance, Clin Sci (Lond), 110, 361, 10.1042/CS20050314
Yudkin, 2005, Vasocrine signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease, Lancet, 365, 1817, 10.1016/S0140-6736(05)66585-3
de Jongh, 2004, Free fatty acid levels modulate microvascular function: relevance for obesityassociated insulin resistance, hypertension, and microangiopathy, Diabetes, 54, 2873, 10.2337/diabetes.53.11.2873
Taheri, 2006, The link between short sleep duration and obesity: we should recommend more sleep to prevent obesity, Arch Dis Child, 91, 881, 10.1136/adc.2005.093013
Watanabe, 2010, Association of short sleep duration with weight gain and obesity at 1-year follow-up: a large-scale prospective study, Sleep, 33, 161, 10.1093/sleep/33.2.161
Xiao, 2013, A large prospective investigation of sleep duration, weight change, and obesity in the NIH-AARP Diet and Health Study cohort, Am J Epidemiol, 178, 1600, 10.1093/aje/kwt180
Holliday, 2013, Short sleep duration is associated with risk of future diabetes but not cardiovascular disease: a prospective study and meta-analysis, PLoS One, 8, 1, 10.1371/journal.pone.0082305
McNeil, 2013, Inadequate sleep as a contributor to obesity and type 2 diabetes, Can J Diabetes, 37, 103, 10.1016/j.jcjd.2013.02.060
Grandner, 2009, From sleep duration to mortality: implications of meta-analysis and future directions, J Sleep Res, 18, 145, 10.1111/j.1365-2869.2009.00753.x
Grandner, 2010, Mortality associated with short sleep duration: the evidence, the possible mechanisms, and the future, Sleep Med Rev, 14, 191, 10.1016/j.smrv.2009.07.006
Taheri, 2004, Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index, PLoS Med, 1, 210, 10.1371/journal.pmed.0010062
Chaput, 2007, Short sleep duration is associated with reduced leptin levels and increased adiposity: results from the Quebec family study, Obesity, 15, 253, 10.1038/oby.2007.512
Spiegel, 1999, Impact of sleep debt on metabolic and endocrine function, Lancet, 354, 1435, 10.1016/S0140-6736(99)01376-8
Spiegel, 2004, Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite, Ann Intern Med, 141, 846, 10.7326/0003-4819-141-11-200412070-00008
Nedeltcheva, 2014, Metabolic effects of sleep disruption, links to obesity and diabetes, Curr Opin Endocrinol Diabetes Obes, 21, 293, 10.1097/MED.0000000000000082
Donga, 2010, A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects, J Clin Endocrinol Metab, 95, 2963, 10.1210/jc.2009-2430
Chennaoui, 2011, Effect of one night of sleep loss on changes in tumor necrosis factor alpha (TNF-alpha) levels in healthy men, Cytokine, 56, 318, 10.1016/j.cyto.2011.06.002
Aho, 2013, Partial sleep restriction activates immune response-related gene expression pathways: experimental and epidemiological studies in humans, PLoS One, 8, 1, 10.1371/journal.pone.0077184
Navarro, 2015, The role of androgens in metabolism, obesity, and diabetes in males and females, Obesity (Silver Spring), 23, 713, 10.1002/oby.21033
Khaw, 1992, Lower endogenous androgens predict central adiposity in men, Ann Epidemiol, 2, 675, 10.1016/1047-2797(92)90012-F
Singh, 2003, Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3 H 10 T1/2 pluripotent cells through an androgen receptor-mediated pathway, Endocrinology, 144, 5081, 10.1210/en.2003-0741
Mootha, 2003, PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet, 34, 267, 10.1038/ng1180
Pitteloud, 2005, Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men, Diabetes Care, 28, 1636, 10.2337/diacare.28.7.1636
Andersson, 1994, Testosterone concentrations in women and men with NIDDM, Diabetes Care, 17, 405, 10.2337/diacare.17.5.405
Oh, 2002, Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study, Diabetes Care, 25, 55, 10.2337/diacare.25.1.55
Tok, 2004, The androgenic profile of women with noninsulin- dependent diabetes mellitus, J Reprod Med., 49, 746
Page-Wilson, 2009, Interrelation between sex hormones and plasma sex hormone-binding globulin and hemoglobin A1 c in healthy postmenopausal women, Metab Syndrome Relat Disord, 7, 249, 10.1089/met.2008.0081
Dreaden, 2012, Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells, Bioconjugate Chem, 23, 1507, 10.1021/bc300158k
Diamond, 1998, Effects of methyltestosterone on insulin secretion and sensitivity in women, J Clin Endocrinol Metab, 83, 4420
Shamma, 1995, The effect of Norplant on glucose metabolism under hyperglycemic hyperinsulinemic conditions, Fertil Steri, 63, 767, 10.1016/S0015-0282(16)57479-2
Polderman, 1994, Induction of insulin resistance by androgens and estrogens, J Clin Endocrinol Metab, 79, 265
Holmang, 1990, Effects of testosterone on muscle insulin sensitivity and morphology in female rats, Am J Physiol, 259, 555
Holmang, 1992, Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats, Am J Physiol, 262, 851
Volzke, 2010, Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men, Int J Androl, 33, 45, 10.1111/j.1365-2605.2009.00953.x
Zulian, 2005, Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile, J Endocrinol Invest, 28, 49, 10.1007/BF03345529
Gambineri, 2006, Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study, J Clin Endocrinol Metab, 91, 3970, 10.1210/jc.2005-2250
Cândido, 2014, Vitamin D. link between osteoporosis, obesity, and diabetes?, Int J Mol Sci, 15, 6569, 10.3390/ijms15046569
Maestro, 2003, Identification of a Vitamin D response element in the human insulin receptor gene promoter, J Steroid Biochem Mol Biol, 84, 223, 10.1016/S0960-0760(03)00032-3
Wolden-Kirk, 2011, and diabetes Its importance for beta cell and immune function, Mol Cell Endocrinol, 347, 106, 10.1016/j.mce.2011.08.016
Alvarez, 2010, Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis, Int J Endocrinol, 2009, 351385
Cunningham, 2011, Secondary hyperparathyroidism: pathogenesis,disease progression, and therapeutic options, Clin J Am Soc Nephrol, 6, 913, 10.2215/CJN.06040710
Soares, 2012, Mechanistic roles for calcium and vitamin D in the regulation of body weight, Obes Rev, 13, 592, 10.1111/j.1467-789X.2012.00986.x
Almerighi, 2009, 1α,25-dihydroxyvitamin D3 inhibits CD40 L-induced pro-inflammatory and immunomodulatory activity in human monocytes, Cytokine, 45, 190, 10.1016/j.cyto.2008.12.009
Jeffery, 2009, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3, J Immunol, 183, 5458, 10.4049/jimmunol.0803217
Chen, 2007, Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation, J Immunol, 179, 1634, 10.4049/jimmunol.179.3.1634
Eftekharian, 2010, In vivo effects of calcitriol on phenotypic and functional properties of dendritic cells, Iran J Immunol, 7, 74
Iantorno, 2014, Gut hormones and endothelial dysfunction in patients with obesity and diabetes, Int J Immunopathol Pharmacol, 27, 433, 10.1177/039463201402700314
Leite-Moreira, 2007, Physiological, pathological and potential therapeutic roles of ghrelin, Drug Discov, 12, 276
Cummings, 2002, Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery, NEJM, 346, 1623, 10.1056/NEJMoa012908
Zhang, 2005, Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake, Science, 310, 996, 10.1126/science.1117255
Tilg H., Moschen A.R., Microbiota and diabetes: an evolving relationship. Gut. (2014). The paper reviews the role of the microbiota in diabetes and provide new aspects regarding its pathophysiological relevance.
Remely, 2014, Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity, Benef Microbes, 5, 33, 10.3920/BM2013.006
Moreno-Indias, 2014, Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus, Front Microbiol, 5, 190, 10.3389/fmicb.2014.00190
Kemp, 2013, Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota, Adipocyte, 2, 188, 10.4161/adip.24776
Jumpertz, 2011, Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans, Am J Clin Nutr, 94, 58, 10.3945/ajcn.110.010132
Furet, 2010, Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers, Diabetes, 59, 3049, 10.2337/db10-0253
Cani, 2008, Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice, Diabetes, 57, 1470, 10.2337/db07-1403
Doyle, 2003, Pharmacological agents that directly modulate insulin secretion, Pharmacol Rev, 55, 105, 10.1124/pr.55.1.7
Srivastava, 2012, Comparing the efficacy and safety profile of sitagliptin versus glimepiride in patients of type 2 diabetes mellitus inadequately controlled with metformin alone, J Assoc Phys India, 60, 27
Defronzo, 2009, Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus, Diabetes, 58, 773, 10.2337/db09-9028
Scheen, 2015, Obesity A new paradigm for treating obesity and diabetes mellitus, Nat Rev Endocrinol, 11, 196, 10.1038/nrendo.2015.3
Nauck, 1986, Reduced incretin effect in type 2 (non-insulin-dependent) diabetes, Diabetologia, 29, 46, 10.1007/BF02427280
Bagger, 2011, Impaired regulation of the incretin effect in patients with type 2 diabetes, J Clin Endocrinol Metab, 96, 737, 10.1210/jc.2010-2435
Campbell, 2013, Pharmacology, physiology, and mechanisms of incretin hormone action, Cell Metab, 17, 819, 10.1016/j.cmet.2013.04.008
Finan, 2015, A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents, Nat Med, 21, 27, 10.1038/nm.3761
Castaneda, 2002, A randomised controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes, Diabetes Care, 25, 2335, 10.2337/diacare.25.12.2335
Boulé, 2001, Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials, JAMA, 286, 1218, 10.1001/jama.286.10.1218
Lambers, 2008, Influence of combined exercise training on indices of obesity, diabetes and cardiovascular risk in type 2 diabetes patients, Clin Rehabil, 22, 483, 10.1177/0269215508084582
Schwingshackl, 2014, Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis, Diabetologia, 57, 1789, 10.1007/s00125-014-3303-z
Church, 2010, Effects of aerobic and resistance training on hemoglobin A1 c levels in patients with type 2 diabetes: a randomized controlled trial, J Am Med Assoc, 304, 2253, 10.1001/jama.2010.1710
Bacchi, 2012, Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study), Diabetes Care, 35, 676, 10.2337/dc11-1655
Boulé, 2003, Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus, Diabetologia, 46, 1071, 10.1007/s00125-003-1160-2
Banz, 2003, Effects of resistance versus aerobic training on coronary artery disease risk factors, Exp Biol Med, 228, 434, 10.1177/153537020322800414
Maiorana, 2001, The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes, J Am Coll Cardiol, 38, 860, 10.1016/S0735-1097(01)01439-5
de Oliveira, 2012, The effect of different training programs on antioxidant status, oxidative stress, and metabolic control in type 2 diabetes, Appl Physiol Nutr Metab, 37, 334, 10.1139/h2012-004
Golbidi, 2012, Antioxidant and anti-inflammatory effects of exercise in diabetic patients, Exp Diabetes Res, 2012, 941868, 10.1155/2012/941868
Sukala, 2013, Exercise improves quality of life in indigenous Polynesian peoples with type 2 diabetes and visceral obesity, J Phys Act Health, 10, 699, 10.1123/jpah.10.5.699
Kaplan, 1987, Effects of diet and exercise interventions on control and quality of life in non-insulin-dependent diabetes mellitus, J Gen Intern Med, 2, 220, 10.1007/BF02596443
Holton, 2003, The effect of an aerobic exercise training program on quality of life in type 2 diabetes, Diabetes Educator, 29, 837, 10.1177/014572170302900513
Kadoglou, 2007, The anti inflammatory effects of exercise training in patients with type 2 diabetes mellitus, Eur J Cardiovasc Prev Rehabil, 14, 837, 10.1097/HJR.0b013e3282efaf50
Kadoglou, 2013, The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with type 2 diabetes, Diabet Med, 30, e41, 10.1111/dme.12055
Balducci, 2010, Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss, Nutr Metab Cardiovasc Dis, 20, 608, 10.1016/j.numecd.2009.04.015
Swift, 2012, Effect of exercise training modality on C-reactive protein in type 2 diabetes, Med Sci Sports Exerc, 44, 1028, 10.1249/MSS.0b013e31824526cc
Jorge, 2011, The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus, Metabolism, 60, 1244, 10.1016/j.metabol.2011.01.006
Lee, 2005, Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without type 2 diabetes, J Appl Physiol, 99, 1220, 10.1152/japplphysiol.00053.2005
Kay, 2006, The influence of physical activity on abdominal fat: a systematic review of the literature, Obes Rev, 7, 183, 10.1111/j.1467-789X.2006.00250.x
Ross, 2004, Exerciseinduced reduction in obesity and insulin resistance in women: a randomized controlled trial, Obes Res, 12, 789, 10.1038/oby.2004.95
Mourier, 1997, Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM Effects of branched-chain amino acid supplements, Diabetes Care, 20, 385, 10.2337/diacare.20.3.385
Colberg, 2010, Exercise and type 2 diabetes the american college of sports medicine and the american diabetes association joint position statement, Diabetes Care, 33, 147, 10.2337/dc10-9990